BRIEF published on 01/16/2025 at 14:11, 1 year 2 months ago First Berlin Equity Research Initiates 'Buy' Rating for Medigene AG Immuno-oncology Stock Rating Biotech Partnerships Medigene AG TCR Therapies
PRESS RELEASE published on 01/16/2025 at 14:06, 1 year 2 months ago Original-Research: Medigene AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research initiates coverage on Medigene AG with a Buy rating and €3.80 price target, highlighting the company's focus on developing T cell receptor-guided cancer therapies First Berlin Equity Research BUY Rating Medigene AG TCR-guided Therapies €3.80 Price Target
Published on 03/26/2026 at 11:07, 20 minutes ago U.S. Mined and Refined Metals as well as Rare Earth Elements to Be Tokenized in Historic American Strategic Minerals and Datavault AI Deal
Published on 03/26/2026 at 11:00, 27 minutes ago Stagwell Expands the Harris Poll's Harrisquest Across Europe
Published on 03/26/2026 at 08:05, 3 hours 22 minutes ago Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 6 hours 32 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 11:03, 24 minutes ago EQS-Adhoc: VIDINEXT AG: Marketing agreement with Telekom Deutschland GmbH
Published on 03/26/2026 at 11:00, 27 minutes ago Genel Energy PLC: Posting of Annual Report and Notice of AGM
Published on 03/26/2026 at 11:00, 27 minutes ago Genel Energy PLC: Report on payments to governments for the year 2025
Published on 03/26/2026 at 11:00, 27 minutes ago ABB Ltd: ABB share buybacks - March 19, 2026 - March 25, 2026
Published on 03/26/2026 at 11:00, 27 minutes ago Independent study reveals 44% ROI with EQS Compliance Cockpit and payback in under six months
Published on 03/26/2026 at 07:30, 3 hours 57 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 16 hours 56 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 17 hours 42 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
